Global Cannabis Leader PharmaCielo positions itself as the world’s largest licensed cannabis producer with licences for unrestricted THC and CBD in Colombia, offering a unique capability for high-volume medical cannabis oil extracts and related products that can support large channel distributors and pharmaceutical collaborators.

B2B Growth Focus The company targets B2B channels including distributors, finished goods manufacturers, research organizations, and pharmaceutical companies, presenting multiple entry points for partnerships, private label opportunities, and co-development of standardized medicinal-grade cannabis oil products.

Strategic Geography With a Canada headquarters for regulatory and financial oversight and Colombian operations with extensive cultivation capacity, PharmaCielo offers a scalable cross-border supply model appealing to customers seeking compliant, vertically integrated sourcing of cannabis oils.

Moderate Revenue Footprint Current revenue is in a lower mid-range ($1M–$10M) with recent funding of $3.5M, suggesting opportunities for sales expansion through larger pharmaceutical partnerships, contract manufacturing, and expanded distribution as demand for medicinal cannabis grows.

Tech and Reliability Utilizes a mix of established tech stacks and cloud infrastructure (AWS, CMS, CRM/marketing tools) which can support scalable e-commerce, customer portals, and data-driven account management for enterprise customers seeking traceability, quality assurance, and regulatory compliance.